Skip to content

Caudal Epidural Injection of Dextrose For Low Back Pain

CompletedPhase 2NCT01547364
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Objective: The purposes of the study are to 1. Explore the immediate and short term (to 48 hour) analgesic potential of epidural D5W in comparison to normal saline. 2. Determine if cumulative benefit results from caudal dextrose injection. 3. Evaluate accuracy of a small needle vertical approach caudal injection that will allow for blind injection of D5W.

Study details

Official title
Blinded Analgesic Effect and 1 Year Outcome of Caudal D5W Injection in All-Comers With Chronic Low Back Pain and Either Buttock or Leg Pain
Interventions
Sponsor
Smigel, Liza, M.D.
Start date
2012-02
Primary completion
2013-10
Sex
All
Age range
from 18 Years to 75 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * More than 3 months of back pain * Some pain below the iliac crest (Either in buttock or in leg) * At least one conservative (non-injection) modality of treatment to include physical therapy, chiropractic/osteopathic manipulation, exercises, drug therapy, and relative rest. * Opiate use absent or controlled * Psychiatric history absent or controlled * Current medical stability * Absent steroid use history or no allergy or intolerance to steroid use Exclusion Criteria: * Unstable neurologic function

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01547364